Omega-H3

Composition and Active Ingredients

• Thiamine nitrate (vitamin B1), 200mg.
• Pyridoxine hydrochloride (vitamin B6), 50mg
• Cyanocobalamin (vitamin B12). 100µg.

• Color E127 (erythrosine) and other excipients.

• Adult: take 1-2 film coated tablets daily.
• So far there is no experience with the treatment in children. The preparation should therefore not be used in children.

• Some cases of angioneurotic oedema have been described (primarily in sensitive.
• patients). Allergic reactions are rare.
• Endocrine disorders.
• The release of prolactin is inhibited.
• Nervous system disorders.
• Individual cases of anxiety have been described (primarily in sensitive patients).
• Pyridoxine stimulates the decarboxylation of levodopa and can reduce its therapeutic effect on Parkinson’s disease, unless a decarboxylase inhibitor is given at the same time.
• With high doses over a long period (> 500 mg per day), rare cases of reversible.
• Peripheral sensory neuropathy has been observed.
• Cardiac disorders.
• Individual cases of tachycardia and collapse have been described (primarily in sensitive patients).
• Gastrointestinal disorders.
• Nausea and haemorrhagia in the gastrointestinal tract have been described (primarily in sensitive patients).
• Hepatobiliary disorders.
• High doses can lead to an increase in SGOT in the serum.
• Skin and subcutaneous tissue disorders.
• Outbreaks of sweating, feeling of weakness, globus symptoms.

Precautions

• Folic acid deficiency
• Iron deficiency
• Kidney disease
• Liver disease
• Pregnant, planning to become pregnant or breastfeeding
• Pregnant, planning to get pregnant or breastfeeding
• Sinus congestion

• For the treatment of folate-deficient megaloblastic anaemia due to malnutrition, malabsorption syndromes (such as coeliac disease or sprue) and increased utilisation as in pregnancy. It should not be used alone in undiagnosed megaloblastic anaemia including in infancy, pernicious anaemia or macrocytic anaemia of unknown aetiology, unless administered with adequate amounts of hydroxocobalamin.
• For the prophylaxis of drug induced folate deficiency e.g., caused by administration of phenytoin, phenobarbital and primidone. (See section 4.5).
• For the prophylaxis against folate deficiency in chronic haemolytic states or in renal dialysis.
• For the prevention of neural tube defects for woman planning a pregnancy and known to be at risk

• Hypersensitivity to the active substance or to any of the excipients listed in section 6.1.
• Long-term folate therapy is contraindicated in any patient with untreated cobalamin deficiency. This can be untreated pernicious anaemia or other cause of cobalamin deficiency, including lifelong vegetarians. In elderly people, a cobalamin absorption test should be done before long-term folate therapy. Folate given to such patients for 3 months or longer has precipitated cobalamin neuropathy. No harm results from short courses of folate
• Folic acid should never be given alone in the treatment of Addisonian pernicious anaemia and other vitamin B₁₂deficiency states because it may precipitate the onset of subacute combined degeneration of the spinal cord
• Folic acid should not be used in malignant disease unless megaloblastic anaemia owing to folate deficiency is an important complication.

• Patients with vitamin B₁₂deficiency should not be treated with folic acid unless administered with adequate amounts of hydroxocobalamin, as it can mask the condition but the subacute irreversible damage to the nervous system will continue. The deficiency can be due to undiagnosed megaloblastic anaemia including in infancy, pernicious anaemia or macrocytic anaemia of unknown aethiology or other cause of cobalamin deficiency, including lifelong vegetarians.
• Caution should be exercised when administering folic acid to patients who may have folate dependent tumours.
• This product is not intended for healthy pregnant women where lower doses are recommended, but for pregnant women with folic acid deficiency or women at risk for the reoccurrence of neural tube defects.
• This product contains lactose monohydrate. Patients with rare hereditary problems of galactose intolerance, total lactase deficiency or glucose – galactose malabsorption should not take this medicine

• Rich in Vitamin A & (DHA) helps to maintain a healthy immune system also beneficial for healthy skin and eyesight.
• Rich in vitamin D For strong and healthy bones.
• Rich in Omega 3 have anti- inflammatory properties.
• (EPA)for the cardiovascular system and helps reduce inflammation.
• Free from Sugar, gluten and yeast containing ingredients.
• Free from artificial additives, preservatives or colors

• This is a combined mineral and vitamin product for adults.
• It contains calcium and vitamin D3.
• content: 20 effervescent tablets

• It may be used to treat conditions caused by low calcium levels such as bone loss (osteoporosis), weak bones (osteomalacia/rickets), decreased activity of the parathyroid gland (hypoparathyroidism), and a certain muscle disease (latent tetany).

• One tablet daily. Please dissolve the effervescent tablet in a glass of drinking water (200 ml)

• Each tablet contains 2500 mg calcium carbonate equivalent to 1000 mg calcium and 22 microgram cholecalciferol equivalents to 880UI vitamin D3

• hypercalcemia,
• hypercalciuria,
• nausea,
• vomiting,
• constipation,
• abdominal pain,
• muscle weakness.

Pharmacodynamics

Side Effects:

Precautions

Dosage

Food(before/after)

List of Contraindications

Pregabalin+Mecobalamin and Pregnancy

Pregabalin+Mecobalamin and Lactation

Lab interference